Summary & Overview
HCPCS G8972: Thromboembolism Risk Assessment, High or Multiple Moderate Factors
HCPCS Level II code G8972 indicates a documented assessment identifying one or more high-risk factors for thromboembolism or more than one moderate-risk factor. Nationally, standardized documentation of thromboembolic risk informs prophylaxis decisions, quality measurement, and hospital reporting. Clear coding for high- and moderate-risk patients supports care coordination and can affect utilization of pharmacologic or mechanical prophylaxis.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage considerations, benchmarking expectations, and clinical context for use of code G8972.
Readers will learn: the clinical meaning of the code and typical settings where the assessment occurs; common documentation elements that support use of the code; how major payers and Medicare approach coverage and coding consistency; and where G8972 fits in quality measurement and hospital workflows. Data not available in the input for specific modifiers, associated taxonomies, ICD-10 mappings, and related codes is noted where applicable.
Billing Code Overview
HCPCS Level II code G8972 describes patients with one or more high-risk factors for thromboembolism or more than one moderate-risk factor for thromboembolism. The service type implied by this description is risk assessment for thromboembolism, which supports clinical decision-making about prophylaxis or monitoring.
Typical site of service for this assessment is inpatient or outpatient clinical settings where risk evaluation is performed, including hospital wards, emergency departments, and ambulatory clinics. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old woman with a history of atrial fibrillation, recent total hip arthroplasty six days prior, and body mass index of 36 presents to the orthopedic clinic for postoperative follow-up. She reports increasing unilateral leg swelling and pain but no shortness of breath. The surgical team documents multiple risk factors for venous thromboembolism (VTE): recent major orthopedic surgery (high risk), obesity (moderate risk), and age over 60 (moderate risk). The clinician assesses VTE risk using a validated risk stratification tool and documents the presence of one or more high-risk factors, qualifying for services described by G8972.
The clinical workflow includes: initial history and focused physical exam; documentation of specific risk factors and counseling about signs and symptoms of deep vein thrombosis (DVT) and pulmonary embolism (PE); ordering diagnostic testing as indicated (e.g., venous duplex ultrasound, D-dimer, or CT pulmonary angiography if PE suspected); initiation or adjustment of pharmacologic prophylaxis (for example, direct oral anticoagulant or low-molecular-weight heparin) or mechanical prophylaxis; and structured follow-up to monitor anticoagulation and wound healing. Documentation should clearly state the number and type of VTE risk factors and the clinical decision tied to the high-risk status that supports billing G8972.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 |